Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies.

Autor: Traunwieser T; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Loos E; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Ottensmeier H; Department of Pediatric Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany., Gastberger K; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Nemes K; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Mynarek M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bison B; Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.; Neuroradiological Reference Center for the Pediatric Brain Tumor (HIT) Studies of the German Society of Pediatric Oncology and Hematology, Faculty of Medicine, University Augsburg, Augsburg, Germany., Kandels D; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Neumayer P; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Neumann-Holbeck A; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany., Lüttich P; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg, University Hospital, Heidelberg, Germany., Baust K; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany., Faulstich-Ritter K; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany., John R; Department Pediatric Hematology and Oncology, Center for Chronically Sick Children (SPZ), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kreisch A; Department of Pediatrics, University Hospital and Medical Faculty Carl-Gustav-Carus, Technische Universität Dresden, Dresden, Germany., Landmann J; Department of Paediatric Haematology and Oncology, Hannover Medical School, Hannover, Germany., Manteufel E; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Justus-Liebig University of Giessen, Giessen, Germany., Nest A; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Prüfe J; Department of Pediatric Hematology and Oncology, Pediatrics III, Essen University Hospital, Essen, Germany., Schubert L; Department of Pediatric Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany., Stamm W; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Timmermann B; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen, Germany., Gerss J; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany., Schlegel PG; Department of Pediatric Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany., Eyrich M; Department of Pediatric Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany., Gnekow AK; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany., Frühwald MC; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.; Bavarian Cancer Research Center, Augsburg, Germany.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 May; Vol. 71 (5), pp. e30910. Date of Electronic Publication: 2024 Feb 11.

The effects of psychosocial aftercare following pediatric chronic pain treatment withstand the coronavirus disease 2019 pandemic: long-term outcomes of a randomized controlled trial.

Autor: Rau LM; German Paediatric Pain Centre, Children's and Adolescents' Hospital Datteln, Datteln, Germany.; Department of Children's Pain Therapy and Paediatric Palliative Care, Witten/Herdecke University, Faculty of Health, School of Medicine, Witten, Germany., Dogan M; German Paediatric Pain Centre, Children's and Adolescents' Hospital Datteln, Datteln, Germany.; Department of Children's Pain Therapy and Paediatric Palliative Care, Witten/Herdecke University, Faculty of Health, School of Medicine, Witten, Germany., Hirschfeld G; Faculty of Business, University of Applied Sciences and Art Bielefeld, Bielefeld, Germany., Blankenburg M; Department of Children's Pain Therapy and Paediatric Palliative Care, Witten/Herdecke University, Faculty of Health, School of Medicine, Witten, Germany.; Paediatric Pain Centre Baden-Württemberg, Department of Pediatric Neurology, Olgahospital Stuttgart, Stuttgart, Germany., Frühwald MC; Pediatrics and Adolescent Medicine, Bavarian Children's Pain Center, University Hospital Augsburg, Germany., Ahnert R; Pediatrics and Adolescent Medicine, Bavarian Children's Pain Center, University Hospital Augsburg, Germany., Braun S; Paediatric Pain Centre Baden-Württemberg, Department of Pediatric Neurology, Olgahospital Stuttgart, Stuttgart, Germany., Marschall U; Department of Medicine and Health Services Research, BARMER Health Insurance, Wuppertal, Germany., Zernikow B; German Paediatric Pain Centre, Children's and Adolescents' Hospital Datteln, Datteln, Germany.; Department of Children's Pain Therapy and Paediatric Palliative Care, Witten/Herdecke University, Faculty of Health, School of Medicine, Witten, Germany.; PedScience Research Institute, Datteln, Germany., Wager J; German Paediatric Pain Centre, Children's and Adolescents' Hospital Datteln, Datteln, Germany.; Department of Children's Pain Therapy and Paediatric Palliative Care, Witten/Herdecke University, Faculty of Health, School of Medicine, Witten, Germany.; PedScience Research Institute, Datteln, Germany.

Publikováno v: Pain reports [Pain Rep] 2024 Dec 24; Vol. 10 (1), pp. e1226. Date of Electronic Publication: 2024 Dec 24 (Print Publication: 2025).

Bridging molecular advancements and clinical challenges in pediatric oncology.

Autor: Kuhlen M; Pediatric and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany. Michaela.Kuhlen@uk-augsburg.de., Frühwald MC; Pediatric and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Publikováno v: World journal of pediatrics : WJP [World J Pediatr] 2024 Dec 19. Date of Electronic Publication: 2024 Dec 19.

Double Heterozygous Pathogenic Variants in TP53 and CHEK2 in Boy with Undifferentiated Embryonal Sarcoma of the Liver.

Autor: Kuhlen M; Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany., Schaller T; Pathology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany., Dintner S; Pathology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany., Stadler N; Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany., Hofmann TG; Institute of Toxicology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany., Schmutz M; Hematology and Oncology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany., Claus R; Pathology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.; Comprehensive Cancer Center Augsburg, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany., Frühwald MC; Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany., Golas MM; Human Genetics, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 25; Vol. 25 (21). Date of Electronic Publication: 2024 Oct 25.

Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemic.

Autor: Reger M; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians University (LMU), Munich, Germany., Manz K; Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany., Kaeuferle T; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians University (LMU), Munich, Germany.; German Center for Infection Research (DZIF), Munich, Germany., Coffey R; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians University (LMU), Munich, Germany., Wotschofsky Z; Department of Pediatrics and Adolescent Medicine, University Hospital, Erlangen, Germany.; Pediatric Oncology Network Bavaria, KIONET, Bavaria, Germany., von Luettichau I; Pediatric Oncology Network Bavaria, KIONET, Bavaria, Germany.; Department of Pediatrics and Children's Cancer Research Center, TUM School of Medicine, Children's Hospital Munich Schwabing, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Bavaria, Germany., Schlegel PG; Pediatric Oncology Network Bavaria, KIONET, Bavaria, Germany.; Bavarian Cancer Research Center (BZKF), Bavaria, Germany.; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Children's Hospital, University of Würzburg, Würzburg, Germany., Frühwald MC; Pediatric Oncology Network Bavaria, KIONET, Bavaria, Germany.; Bavarian Cancer Research Center (BZKF), Bavaria, Germany.; Pediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Medical Center Augsburg, Augsburg, Germany., Corbacioglu S; Pediatric Oncology Network Bavaria, KIONET, Bavaria, Germany.; Bavarian Cancer Research Center (BZKF), Bavaria, Germany.; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany., Metzler M; Department of Pediatrics and Adolescent Medicine, University Hospital, Erlangen, Germany.; Pediatric Oncology Network Bavaria, KIONET, Bavaria, Germany.; Bavarian Cancer Research Center (BZKF), Bavaria, Germany., Feuchtinger T; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians University (LMU), Munich, Germany.; German Center for Infection Research (DZIF), Munich, Germany.; Pediatric Oncology Network Bavaria, KIONET, Bavaria, Germany.; Bavarian Cancer Research Center (BZKF), Bavaria, Germany.; Pediatric Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany.

Publikováno v: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2024 Oct; Vol. 41 (7), pp. 504-518. Date of Electronic Publication: 2024 Sep 05.